Ghisallo Capital Management »

Cytokinetics shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $15M 170k 85.19
2024-06-30 $11M 196k 54.18

More positions owned by Ghisallo Capital Management

Space Exploration Techn Corp Class A Com Stk (SPCX)
Digital Realty Trust (DLR)
Midea 051333 Cvt Put Convertible Bond (Principal)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Super Micro Computer Com New (SMCI)
Medline Com Cl A (MDLN)
Nebius Group Shs Class A (NBIS)
Xpeng Ads (XPEV)
Midea 051127 Cvt Convertible Bond (Principal)
Aurora Innovation Class A Com (AUR)
Ztoec 0925 030131 Cvt Put Convertible Bond (Principal)
American Electric Power Company (AEP)
Forgent Power Solutions Com Shs Cl A (FPS)
Lnvgy 062533 Cvt Convertible Bond (Principal)

View all positions for Ghisallo Capital Management

Top funds holding Cytokinetics

BlackRock
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
venBio Select Advisor
Bank of America Corporation
Susquehanna International
Geode Capital Management
Rtw Investments
Armistice Capital
Polar Capital Holdings
Citadel Advisors
Goldman Sachs Group

View all funds holding Cytokinetics